Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-09-12
Target enrollment:
Participant gender:
Summary
This phase II clinical trial is studying how well azacitidine works in treating patients with
previously treated advanced non-small cell lung cancer. Drugs used in chemotherapy, such as
azacitidine, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing.